Understanding how the body clears damaged cells to improve treatments for diseases like Batten disease
Elucidating and harnessing the molecular mechanisms of protective clearance in endogenous and engineered phagocytes
This study is looking at how the body safely gets rid of damaged cells in the brain, which is important for understanding diseases like Batten disease, and it hopes to find new ways to help people with neurodegenerative conditions.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bryn Mawr College NIH-funded |
| Lab location | 1 site (Bryn Mawr, United States) |
| Project ID | NIH-10729935 on NIH RePORTER |
What this research studies
This research investigates the process of protective clearance, which is how the body removes damaged or dead cells without causing inflammation. It focuses on understanding the molecular mechanisms involved in this process, particularly in the central nervous system, where issues can lead to severe conditions like Batten disease. By studying how certain proteins function in this clearance process, the research aims to uncover new treatment strategies for neurodegenerative diseases. Patients may benefit from insights that could lead to innovative therapies targeting the underlying causes of these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Batten disease or other related lysosomal storage disorders.
Not a fit: Patients with conditions unrelated to lysosomal storage disorders or those not experiencing issues with protective clearance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurodegenerative diseases, improving the quality of life for affected patients.
How similar studies have performed: Previous research has shown promise in understanding similar mechanisms in other neurodegenerative diseases, suggesting potential for success in this area as well.
Where this research is happening
Bryn Mawr, United States
- Bryn Mawr College — Bryn Mawr, United States (Active)
Researchers
- Principal investigator: Williamson, Adam Patrick — Bryn Mawr College
- Study coordinator: Williamson, Adam Patrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.